ABT vs. STE: Abbott Laboratories vs. STERIS Stock Comparison
How do Abbott Laboratories (ABT) and STERIS (STE) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and STERIS (STE) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | ABT | STE |
|---|---|---|
| Name | Abbott Laboratories | STERIS plc |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 190.39 billion USD | 24.50 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | June 1, 1992 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | STE |
|---|---|---|
| Total Return (1Y) | -10.78% | -1.85% |
| Total Return (3Y, Annualized) | 7.79% | 9.57% |
| Total Return (5Y, Annualized) | -0.79% | 3.26% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | STE |
|---|---|---|
| Volatility (1Y, Annualized) | 28.48% | 26.39% |
| Beta (5Y) | 0.53 | 0.81 |
| Max Drawdown (5Y) | -39.64% | -36.18% |
| Avg. Volume (3M) | 8.74M | 694.02K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | STE |
|---|---|---|
| Sharpe Ratio (1Y) | -0.53 | -0.23 |
| Sortino Ratio (1Y) | -0.76 | -0.34 |
Profitability
ROE (TTM)
Both Abbott Laboratories (ABT) at 9.14% and STERIS (STE) at 11.61% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
ABT
Health Care Equipment & Services industry group
9.14%
- Max
- 47.61%
- Q3
- 14.36%
- ABT
- 9.14%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
STE
Health Care Equipment & Services industry group
11.61%
- Max
- 47.61%
- Q3
- 14.36%
- STE
- 11.61%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Abbott Laboratories (ABT) at 9.75% and STERIS (STE) at 13.41% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
ABT
Health Care Equipment & Services industry group
9.75%
- Max
- 29.35%
- ABT
- 9.75%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
STE
Health Care Equipment & Services industry group
13.41%
- Max
- 29.35%
- STE
- 13.41%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
STERIS (STE) at 19.18% operates in the top operating margin quartile, ahead of Abbott Laboratories (ABT) at 11.66%, which runs around its industry’s norm.
ABT
Health Care Equipment & Services industry group
11.66%
- Max
- 35.43%
- Q3
- 14.14%
- ABT
- 11.66%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
STE
Health Care Equipment & Services industry group
19.18%
- Max
- 35.43%
- STE
- 19.18%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ABT | STE |
|---|---|---|
| ROE (TTM) | 9.14% | 11.61% |
| ROA (TTM) | 4.90% | 7.00% |
| Net Margin (TTM) | 9.75% | 13.41% |
| Operating Margin (TTM) | 11.66% | 19.18% |
| Gross Margin (TTM) | 57.17% | 44.30% |
Growth
Revenue Growth
Both Abbott Laboratories (ABT) at 5.67% and STERIS (STE) at 8.73% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
STERIS (STE) at 27.90% sits in the top EPS growth quartile, while Abbott Laboratories (ABT) at -51.31% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | ABT | STE |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 8.73% |
| Revenue Growth (3Y CAGR) | 0.51% | 9.38% |
| EPS Growth (YoY) | -51.31% | 27.90% |
| EPS Growth (3Y CAGR) | -1.65% | 94.97% |
Financial Strength
Current Ratio (MRQ)
Both Abbott Laboratories (ABT) at 1.46 and STERIS (STE) at 2.05 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
ABT
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ABT
- 1.46
- Q1
- 1.37
- Min
- 0.30
STE
Health Care Equipment & Services industry group
2.05
- Max
- 7.59
- Q3
- 4.00
- STE
- 2.05
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Abbott Laboratories (ABT) at 0.61 and STERIS (STE) at 0.28 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
ABT
Health Care Equipment & Services industry group
0.61
- Max
- 1.88
- Q3
- 0.91
- ABT
- 0.61
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
STE
Health Care Equipment & Services industry group
0.28
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- STE
- 0.28
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | ABT | STE |
|---|---|---|
| Current Ratio (MRQ) | 1.46 | 2.05 |
| Debt / Equity (MRQ) | 0.61 | 0.28 |
| Net Debt / EBITDA | 2.37 | 0.91 |
Dividends
Dividend Yield (TTM)
Both Abbott Laboratories (ABT) at 2.22% and STERIS (STE) at 1.02% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
ABT
Health Care Equipment & Services industry group
2.22%
- ABT
- 2.22%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
STE
Health Care Equipment & Services industry group
1.02%
- STE
- 1.02%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Abbott Laboratories (ABT) at 92.54% and STERIS (STE) at 30.61% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
ABT
Health Care Equipment & Services industry group
92.54%
- ABT
- 92.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
STE
Health Care Equipment & Services industry group
30.61%
- STE
- 30.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | STE |
|---|---|---|
| Dividend Yield (TTM) | 2.22% | 1.02% |
| Dividend Payout Ratio (TTM) | 92.54% | 30.61% |
Valuation
P/E Ratio (TTM)
Both Abbott Laboratories (ABT) at 41.02 and STERIS (STE) at 29.93 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
ABT
Health Care Equipment & Services industry group
41.02
- Max
- 80.41
- Q3
- 47.62
- ABT
- 41.02
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
STE
Health Care Equipment & Services industry group
29.93
- Max
- 80.41
- Q3
- 47.62
- STE
- 29.93
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and STERIS (STE) at 3.97 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
ABT
Health Care Equipment & Services industry group
3.95
- Max
- 8.80
- Q3
- 4.32
- ABT
- 3.95
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
STE
Health Care Equipment & Services industry group
3.97
- Max
- 8.80
- Q3
- 4.32
- STE
- 3.97
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and STERIS (STE) at 3.38 are valued close to their industries’ norm against book — neither stands out from peers.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 11.68
- Q3
- 6.12
- ABT
- 3.73
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
STE
Health Care Equipment & Services industry group
3.38
- Max
- 11.68
- Q3
- 6.12
- STE
- 3.38
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ABT | STE |
|---|---|---|
| P/E Ratio (TTM) | 41.02 | 29.93 |
| P/S Ratio (TTM) | 3.95 | 3.97 |
| P/B Ratio (MRQ) | 3.73 | 3.38 |
| Free Cash Flow Yield (TTM) | 3.19% | 3.36% |